Original Query: ALL
Previous Study | Return to List | Next Study

A Dose Escalation of Gimatecan Administered Orally to Japanese Patients With Advanced Solid Tumor.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00410358
Recruitment Status : Completed
First Posted : December 12, 2006
Last Update Posted : October 16, 2012
Information provided by (Responsible Party):
Novartis ( Novartis Pharmaceuticals )

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : February 2008
  Study Completion Date : No date given